Aktie A011000 GENEONE LIFE SCIENCE, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen GeneOne Life Science, Inc.

Aktien

A011000

KR7011000007

A011000

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 02.07.2024 		% 5 Tage % 1. Jan.
2’120 KRW +0.95% Intraday Chart für GeneOne Life Science, Inc. +0.95% -25.35%
16.05. GeneOne Life Science, Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024 CI
27.03. GeneOne Life Science, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
GeneOne Life Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
GeneOne Life Science, Inc. announced that it has received KRW 3.6000014 billion in funding
GeneOne Life Science, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
GeneOne Life Science, Inc. announced that it expects to receive KRW 3.6000014 billion in funding
GeneOne Life Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
GeneOne Life Science, Inc. announced that it has received KRW 2.46998556 billion in funding
Gene One Life Science to Raise 2.5 Billion Won via Stock Sale
GeneOne Life Science, Inc. announced that it expects to receive KRW 2.46998556 billion in funding
GeneOne Life Science, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Gene One Life Science to Raise 80 Billion Won via Share Sale
GeneOne Life Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
GeneOne Life Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Varicella Zoster Infections Pipeline Landscape Analysis of 03+ Companies by DelveInsight | Leading Companies - Curevo Vaccine, GeneOne Life Science, SK Bioscience, and Others
GeneOne Life Science, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
GeneOne Life Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
GeneOne Life Science, Inc. announced that it has received KRW 11.7 billion in funding
GeneOne Life Science, Inc. announced that it expects to receive KRW 11.7 billion in funding
GeneOne Life Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
SK bioscience : S.Korea to begin producing Novavax COVID-19 vaccine as early as June
GeneOne Life Science : VGXI and Geneos Therapeutics Expand Partnership for Personalized Cancer Immunotherapies
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A011000 Aktie
  4. Nachrichten GeneOne Life Science, Inc.
  5. Andere Sprachen